Cumberland Pharmaceuticals Files 8-K on Shareholder Votes
Ticker: CPIX · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1087294
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
Related Tickers: CPRX
TL;DR
CPRX filed an 8-K for shareholder votes, nothing major to see here yet.
AI Summary
Cumberland Pharmaceuticals Inc. filed an 8-K on April 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or outcomes, but it serves as an official record of the company's compliance with reporting requirements.
Why It Matters
This filing indicates that Cumberland Pharmaceuticals held or is holding a shareholder vote, which is a standard corporate governance procedure. The lack of specific details suggests no immediate material changes are being announced through this particular filing.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for a shareholder vote, with no immediate financial or operational disclosures that would indicate high risk.
Key Numbers
- 001-33637 — SEC File Number (Identifies the company's filing history with the SEC.)
- 62-1765329 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Registrant
- April 28, 2025 (date) — Date of Report
- Tennessee (location) — State of incorporation
- Nashville (location) — Principal Executive Offices City
FAQ
What specific matters were submitted to a vote of Cumberland Pharmaceuticals Inc. security holders?
The provided filing (Form 8-K) does not specify the exact matters submitted for a vote. It only indicates that such matters were presented.
When was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 28, 2025.
What is Cumberland Pharmaceuticals Inc.'s principal executive office address?
The principal executive offices are located at 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934.
What is the SIC code for Cumberland Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Cumberland Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).